BG103414A - N-(imidazolylbutyl)benzenesulphonamide derivatives, method for their prepraration and application as medicaments - Google Patents

N-(imidazolylbutyl)benzenesulphonamide derivatives, method for their prepraration and application as medicaments

Info

Publication number
BG103414A
BG103414A BG103414A BG10341499A BG103414A BG 103414 A BG103414 A BG 103414A BG 103414 A BG103414 A BG 103414A BG 10341499 A BG10341499 A BG 10341499A BG 103414 A BG103414 A BG 103414A
Authority
BG
Bulgaria
Prior art keywords
group
alkyl
prepraration
imidazolylbutyl
medicaments
Prior art date
Application number
BG103414A
Other languages
Bulgarian (bg)
Inventor
Jean-Michel Altenburger
Gilbert Lassalle
Valerie Martin
Daniel Galtier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of BG103414A publication Critical patent/BG103414A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Abstract

The compounds have the formula where R1 and R'1 mean hydrogen, halogen or (C1-C4)alkyl, R2 means piperidin-1-yl, 1,2,3,6-tetrahydropyridon-yl, optionally substituted hexahydro-1H-azepin-1-yl, heptahydroazocyn-1-yl or octahydro-1H-azonine-1-yl group or the group where a-B is -CONR'', m is of the value from 1 to 2, and p - from 1 to 2 where Q is carbon or nitrogen atom, D is (C1-C4)-alkyl or -COR5, R5 being (C1-C4)alkyl, -(CH2)nOCH3, -CH20(CH2H40)nCH3, -(CH2)nCF3 or -(CH2)nOH, n having the value of from 1 to 4; -SO2R6 group, -CONHR6 group, or -SO2N(R6)2 group, R6 being (C1-C6) alkyl; R4 is hydrogen or halogen and A is phenyl or heterocyclyl, optionally substituted, or cyclo (C5-C8)-alkyl group. The invention also relates to a method for the preparation of the above compounds and to their administration as medicamentous forms. 10 claims
BG103414A 1996-11-22 1999-05-19 N-(imidazolylbutyl)benzenesulphonamide derivatives, method for their prepraration and application as medicaments BG103414A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614309A FR2756285B1 (en) 1996-11-22 1996-11-22 N- (IMIDAZOLYLBUTYL) BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
PCT/FR1997/002079 WO1998022443A1 (en) 1996-11-22 1997-11-19 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application

Publications (1)

Publication Number Publication Date
BG103414A true BG103414A (en) 2000-01-31

Family

ID=9497920

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103414A BG103414A (en) 1996-11-22 1999-05-19 N-(imidazolylbutyl)benzenesulphonamide derivatives, method for their prepraration and application as medicaments

Country Status (20)

Country Link
EP (1) EP0946517A1 (en)
JP (1) JP2001504128A (en)
KR (1) KR20000069063A (en)
CN (1) CN1238765A (en)
AR (1) AR009627A1 (en)
AU (1) AU5226498A (en)
BG (1) BG103414A (en)
BR (1) BR9713291A (en)
CA (1) CA2270478A1 (en)
CO (1) CO4910158A1 (en)
CZ (1) CZ178299A3 (en)
EE (1) EE9900201A (en)
FR (1) FR2756285B1 (en)
HU (1) HUP9904599A2 (en)
IL (1) IL129546A0 (en)
NO (1) NO992436L (en)
SK (1) SK66799A3 (en)
TR (1) TR199901143T2 (en)
WO (1) WO1998022443A1 (en)
ZA (1) ZA9710515B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783521B1 (en) * 1998-09-18 2002-04-26 Synthelabo N- (ARGINYL) BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2806722B1 (en) 2000-03-23 2002-05-17 Sanofi Synthelabo N- (HETEROCYCLYLBUTYL) BENZENE- OR PYRIDINE SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
EP3201168B1 (en) 2014-09-29 2020-03-18 Cellix Bio Private Limited Compounds and compositions for the treatment of multiple sclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689130B1 (en) * 1992-03-30 1994-05-27 Synthelabo DERIVATIVES OF 1- [2 (ARYLSULFONYLAMINO) ETHYL-1-OXO] PIPERIDINE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
FR2710066B1 (en) * 1993-09-14 1995-10-20 Synthelabo 1- [2-amino-5- [1- (triphenylmethyl-1H-imidazol-4-yl] -1-oxopentyl] piperidine derivatives, their preparation and their use as synthesis intermediates.
FR2727410B1 (en) * 1994-11-25 1996-12-20 Synthelabo SULFONYL CHLORIDES, THEIR PREPARATION AND THEIR USE AS SYNTHESIS INTERMEDIATES
FR2728570B1 (en) * 1994-12-23 1997-04-11 Synthelabo 1-OXO-2- (PHENYLSULFONYLAMINO) PENTYLPIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE19548797A1 (en) * 1995-12-27 1997-07-03 Thomae Gmbh Dr K New amino-imidazole substituted amino acid derivatives

Also Published As

Publication number Publication date
BR9713291A (en) 1999-10-26
EE9900201A (en) 1999-12-15
AU5226498A (en) 1998-06-10
SK66799A3 (en) 2000-02-14
HUP9904599A2 (en) 2000-06-28
IL129546A0 (en) 2000-02-29
NO992436D0 (en) 1999-05-20
CN1238765A (en) 1999-12-15
CA2270478A1 (en) 1998-05-28
CZ178299A3 (en) 1999-08-11
WO1998022443A1 (en) 1998-05-28
ZA9710515B (en) 1998-06-10
CO4910158A1 (en) 2000-04-24
FR2756285A1 (en) 1998-05-29
NO992436L (en) 1999-07-22
FR2756285B1 (en) 1998-12-18
JP2001504128A (en) 2001-03-27
AR009627A1 (en) 2000-04-26
EP0946517A1 (en) 1999-10-06
KR20000069063A (en) 2000-11-25
TR199901143T2 (en) 1999-08-23

Similar Documents

Publication Publication Date Title
GB9526245D0 (en) Chemical compounds
AU671933B2 (en) The administration of monoamine acridine in cholinergic neuronal deficit states
HUP9701096A2 (en) Use of benzenesulfonamides for the preparation of pharmaceutical compositions treating disorders of the central nervous system, novel derivatives, process for their preparation and pharmaceutical compositions containing them
MXPA03007248A (en) Quinazolines as mmp-13 inhibitors.
HUP0400837A2 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
EP0703222A4 (en) 3-aminoazepine compound and pharmaceutical use thereof
FR2712591B1 (en) New arylpiperazines derived from indole, their preparation and their therapeutic use.
HUP0002853A2 (en) 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, and pharmaceutical compositions containing them
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
MY103348A (en) Heteroaryl 3-0x0-propanenitrile derivatives and process for their preparation
DK0424244T3 (en) 3-aryl-oxazolidinone derivatives, process for their preparation and therapeutic use thereof
ATE36151T1 (en) NEW SUBSTITUTED PYRROLIDINONES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICALS.
BG103414A (en) N-(imidazolylbutyl)benzenesulphonamide derivatives, method for their prepraration and application as medicaments
HUP0104224A2 (en) Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors
ZA9510908B (en) Pharmaceutical compounds
HU9503090D0 (en) Novel bisoxadiazolidine derivative
ATE212227T1 (en) USE OF COMPOCEDINE DERIVATIVES TO INHIBIT THE FORMATION OR SECRETION OF BETA-AMYLOID PROTEIN
KR970009570B1 (en) Intermediates of aminobenzoic acid
CA2266565A1 (en) Azabicyclic rotomase inhibitors
AU4713697A (en) Process for the preparation of N-(2-(dimethylamino)ethyl)acridine-4-carboxamide
ES2010225A6 (en) 2,6-Piperazine-dione derivatives, processes for their preparation and pharmaceutical compositions containing them.
BR9812928A (en) New 3-oxo- (2h) -1,2,4-triazine derivatives, process for preparing chemical compounds, and pharmaceutical composition
NO963307L (en) Karbamoylmetylureaderivater
PL334073A1 (en) Diphenylalkyl tetrahydropyridines, method of obtaining them and compositions containing such compounds
NO944909L (en) Methods for inhibiting male infertility